Cargando…

Therapeutic Strategies for Immune Transformation in Parkinson’s Disease

Dysregulation of innate and adaptive immunity can lead to alpha-synuclein (α-syn) misfolding, aggregation, and post-translational modifications in Parkinson’s disease (PD). This process is driven by neuroinflammation and oxidative stress, which can contribute to the release of neurotoxic oligomers t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saleh, Maamoon, Markovic, Milica, Olson, Katherine E., Gendelman, Howard E., Mosley, R. Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535567/ https://www.ncbi.nlm.nih.gov/pubmed/35871362 http://dx.doi.org/10.3233/JPD-223278

Ejemplares similares

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
por: Markovic, Milica, et al.
Publicado: (2022)

Prodrug Therapies for Infectious and Neurodegenerative Diseases
por: Markovic, Milica, et al.
Publicado: (2022)

Immunotherapy for Parkinson’s disease
por: Schwab, Aaron D., et al.
Publicado: (2020)

Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders
por: Anderson, Kristi M, et al.
Publicado: (2014)

Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
por: Abdelmoaty, Mai M., et al.
Publicado: (2022)

An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
por: Olson, Katherine E., et al.
Publicado: (2023)

Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson’s disease
por: Schutt, Charles R., et al.
Publicado: (2018)

Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
por: Olson, Katherine E., et al.
Publicado: (2021)

Humanized Mice for Infectious and Neurodegenerative disorders
por: Dash, Prasanta K., et al.
Publicado: (2021)

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease
por: Mosley, R. Lee, et al.
Publicado: (2019)

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
por: Machhi, Jatin, et al.
Publicado: (2020)

Clinical biomarkers for Lewy body diseases
por: Abdelmoaty, Mai M., et al.
Publicado: (2023)

Specific Transfection of Inflamed Brain by Macrophages: A New Therapeutic Strategy for Neurodegenerative Diseases
por: Haney, Matthew J., et al.
Publicado: (2013)

Neuromagnetic Evidence of Abnormal Movement-Related Beta Desynchronization in Parkinson's Disease
por: Heinrichs-Graham, Elizabeth, et al.
Publicado: (2014)

Multidimensional protein fractionation using ProteomeLab PF 2D™ for profiling amyotrophic lateral sclerosis immunity: A preliminary report
por: Schlautman, Joshua D, et al.
Publicado: (2008)

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
por: Abdelmoaty, Mai M., et al.
Publicado: (2021)

The cortical signature of symptom laterality in Parkinson's disease
por: Heinrichs-Graham, Elizabeth, et al.
Publicado: (2017)

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
por: Gendelman, Howard E., et al.
Publicado: (2017)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
por: Sarkar, Sumit, et al.
Publicado: (2016)

CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
por: Saunders, Jessica A. Hutter, et al.
Publicado: (2012)

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008)

Tissue Engineering Through 3D Bioprinting to Recreate and Study Bone Disease
por: Pavek, Adriene, et al.
Publicado: (2021)

Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
por: De Lazzari, Federica, et al.
Publicado: (2018)

Targeting RNA: A Transformative Therapeutic Strategy
por: Yin, Wei, et al.
Publicado: (2019)

Gene-Based Therapeutics for Parkinson’s Disease
por: Shalaby, Karim E., et al.
Publicado: (2022)

A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy
por: Araínga, Mariluz, et al.
Publicado: (2017)

Immune senescence in aged APP/PS1 mice
por: Abdelmoaty, Mai M., et al.
Publicado: (2023)

New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
por: Lorente-Picón, Marina, et al.
Publicado: (2021)

Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson’s Disease
por: Jin, Wook
Publicado: (2020)

Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
por: Gouda, Noha A., et al.
Publicado: (2022)

Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders
por: Senjor, Emanuela, et al.
Publicado: (2023)

URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease
por: Kiyota, Tomomi, et al.
Publicado: (2018)

Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease
por: Roy, Avik, et al.
Publicado: (2012)

Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies
por: Ma, L., et al.
Publicado: (2021)

Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
por: Benner, Eric J., et al.
Publicado: (2008)

Drosophila Models of Parkinson's Disease: Discovering Relevant Pathways and Novel Therapeutic Strategies
por: Muñoz-Soriano, Verónica, et al.
Publicado: (2011)

Immune Responses in Parkinson's Disease: Interplay between Central and Peripheral Immune Systems
por: Su, Xiaomin, et al.
Publicado: (2014)

Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review
por: Picchianti Diamanti, Andrea, et al.
Publicado: (2016)

Future Therapeutic Strategies for Freezing of Gait in Parkinson’s Disease
por: Cui, Cathy K., et al.
Publicado: (2021)

Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s Disease?
por: Vilaça-Faria, Helena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jol6hk6dnh6qkudoc61oqkpa9p